$ICCC
Immucell Corp
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
$9.98
▲+3.85%+$0.370
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateImmucell Corp
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
Why is ICCC up today? It is at $9.98 (+3.85%). See the catalyst behind the move, real-time alerts the moment ICCC spikes, and full due diligence on ICCC — key stats, earnings, dilution and insider activity. Free.
Be first to know when $ICCC makes an unusual move. Create a free account to track $ICCC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ICCC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ICCC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Te Boekhorst Paul Francis Olivier Officer | Bought (open market) | +8K 0.09% of company | added 82% | 18K | $76K at $9.49 | Jun 18, 26 |
Brigham Michael F Director | Sold (automatic/other) | -24K 0.3% of company | sold 10% | 206K | $146K at $6.07 | Mar 20, 26 |
Brigham Michael F Director | Other | 25K 0.3% of company | added 12% | 230K | $146K at $5.84 | Mar 20, 26 |
Te Boekhorst Paul Francis Olivier Officer | Bought (open market) | +6K 0.07% of company | added 100% | 10K | $30K at $5.00 | Dec 3, 25 |
Te Boekhorst Paul Francis Olivier Officer | Bought (open market) | +4K 0.04% of company | n/a | 4K | $18K at $4.87 | Dec 2, 25 |
Tomsche David Scott Director | Bought (open market) | +2K 0.02% of company | added 3.2% | 53K | $8K at $4.76 | Nov 25, 25 |
Tomsche David Scott Director | Bought (open market) | +2K 0.02% of company | added 2.1% | 79K | $8K at $4.76 | Nov 25, 25 |
Gathagan Bryan K. Director | Bought (open market) | +1K 0.01% of company | n/a | 1K | $6K at $6.32 | Jun 12, 25 |
Basse Gloria F Director | Other | 4K 0.04% of company | n/a | 4K | $17K at $4.81 | Jun 11, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
Here is the latest on ICCC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ICCC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ICCC last traded at $9.98, up 3.85% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ICCC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ICCC 0 times in the last 30 days.
ICCC (Immucell Corp) trades on XNAS, with a market cap of about $87M in the In Vitro & In Vivo Diagnostic Substances sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ICCC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ICCC discussion
Sign in to ask a question or join the discussion.